3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
4
Rectal Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroendocrine Tumors
1
Myocarditis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Extranodal NK-T-Cell
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Carcinoma in Situ
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
pembrolizumab
26
Paclitaxel
25
Carboplatin
19
Bevacizumab
13
Specimen Handling
11
Magnetic Resonance Spectroscopy
9
Doxorubicin
8
Cisplatin
8
Taxes
7
Biopsy
7
olaparib
6
lenvatinib
6
Fulvestrant
6
durvalumab
5
dostarlimab
5
Nivolumab
5
Megestrol Acetate
5
Letrozole
5
Gemcitabine
5
Docetaxel
5
trastuzumab deruxtecan
4
Trastuzumab
4
Tirzepatide
4
Progestins
4
Medroxyprogesterone Acetate
4
Fluorouracil
4
palbociclib
3
ipatasertib
3
atezolizumab
3
abemaciclib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
Tomography, X-Ray Computed
×
90 days
×
Clear all
No trials found.